Compare iShares Global Clean Energy ETF (ICLN) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Clean Energy ETF vs Smith & Nephew plc — how do they compare? iShares Global Clean Energy ETF trades at $17.28 (market cap $2.27B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 4.9× iShares Global Clean Energy ETF's market cap, and Smith & Nephew plc pays a 2.95% dividend while iShares Global Clean Energy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Global Clean Energy ETF for 87 Days and Smith & Nephew plc for 121 Days on average.
| ICLN | SNN | |
|---|---|---|
Market Cap | $2.27B | $11.10B |
Volume | 6,845,064 | 1,051,703 |
52-Week High | $23.75 | $37.17 |
52-Week Low | $15.78 | $26.42 |
Typical Hold Time | 87 Days | 121 Days |
Sector | — | Health |
Enterprise Value | — | $14.13B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICLN trades at $17.12, down 1.1% today, with a bearish technical signal from moving averages and neutral oscillators. The ETF faces volatility in clean energy markets, with recent comparisons highlighting deeper drawdowns versus traditional energy ETFs. News indicates global renewable energy acceleration due to geopolitical tensions, potentially benefiting ICLN's long-term theme.
The outlook remains cautious near-term due to technical weakness and competitive fee pressures, but long-term growth prospects are supported by energy transition trends. Key risks include high volatility, expense ratios, and fossil fuel competition. Analyst sentiment is mixed, weighing near-term headwinds against structural shifts.
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
